Uveal Melanoma, Recurrent
2 clinical trials · Condition
◉ Watch Uveal Melanoma, Recurrent
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma (NCT07136181) | Novelwise Pharmaceutical Corporation | 2025-11-20 |
| A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (NCT06022029) | OncoNano Medicine, Inc. | 2023-10-13 |
Track Uveal Melanoma, Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.